Bausch & Lomb Sunglass Divestiture To Luxottica Will Help Fund Expansion
This article was originally published in The Gray Sheet
Bausch & Lomb plans to use net proceeds from its $640 mil. cash divestiture of its Rochester, New York-based sunglass operation to Luxottica Group S.p.A. to augment its core portfolio of vision care, pharmaceuticals and ophthalmic surgery products.
You may also be interested in...
Bausch & Lomb plans to eliminate 7% of its workforce over the next 12 months in response to increased global competition in the contact lens market, Chairman and CEO William Carpenter announced during a Dec.1 teleconference.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.